A Comparative Analysis of Current Lipid Treatment Guidelines Nothing Stands Still

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

卷:71

Article

Tibrewala, Anjan¹  Jivan, Arif¹  Oetgen, William J.²  Stone, Neil J.¹ 

[1] Northwestern Univ, Div Cardiol, Feinberg Sch Med, 676 North St Clair St,Suite 600, Chicago, IL 60611 USA

[2] Amer Coll Cardiol, Washington, DC USA

关键词: atherosclerotic cardiovascular disease;    cholesterol;    lipid;    primary prevention;    secondary prevention;    statin;   

DOI  :  10.1016/j.jacc.2017.12.025

来源: Elsevier

【 摘 要 】

Lipid treatment guidelines have continued to evolve as new evidence emerges. We sought to review similarities and differences of 5 lipid treatment guidelines from the American College of Cardiology/American Heart Association, Canadian Cardiovascular Society, European Society for Cardiology/European Atherosclerosis Society, U.S. Preventive Services Task Force, and U.S. Veterans Affairs/Department of Defense. All guidelines utilize rigorous evidentiary review, highlight statin therapy for primary and secondary prevention of atherosclerotic cardiovascular disease, and emphasize a clinician-patient risk discussion. However, there are differences in statin intensities, use of risk estimators, treatment of specific patient subgroups, and consideration of safety concerns. Clinicians should understand these similarities and differences in current and future guideline recommendations when considering if and how to treat their patients with statin therapy. (c) 2018 by the American College of Cardiology Foundation.

【 授权许可】

Free